BiPAP in Acute Pulmonary Embolism with Respiratory Failure
For adults with acute pulmonary embolism who develop hypoxemic respiratory failure, initiate supplemental oxygen targeting SpO₂ 94-98% (or 88-92% if at risk for hypercapnia), and consider BiPAP only if there is concurrent hypercapnic respiratory failure (Type 2) with acidosis, such as in patients with underlying COPD or obesity hypoventilation syndrome. 1
Initial Oxygen Management
Most patients with pulmonary embolism are not hypoxemic and do not require oxygen therapy 1. When hypoxemia is present:
- Target SpO₂ 94-98% in patients without risk factors for hypercapnia 1
- Target SpO₂ 88-92% if the patient has COPD or other risk factors for hypercapnic respiratory failure 1
- Start with nasal cannulae at 2-6 L/min or simple face mask at 5-10 L/min 1
- Use reservoir mask at 15 L/min if initial SpO₂ is below 85% 1
When to Consider BiPAP vs CPAP
BiPAP is indicated specifically for Type 2 respiratory failure (hypercapnic with acidosis), not for pure hypoxemic failure 2, 3:
Use BiPAP if:
- PaCO₂ >45 mmHg (6 kPa) AND pH <7.35 2, 3
- Patient has underlying COPD, obesity hypoventilation syndrome, or neuromuscular disease 2, 4
- Patient shows signs of respiratory muscle fatigue with elevated CO₂ 2
Use CPAP instead if:
- Pure hypoxemic respiratory failure (normal or low PaCO₂) 2, 3
- Cardiogenic pulmonary edema component 3, 1
- FiO₂ requirement <0.4 with adequate respiratory drive 2
BiPAP Settings and Monitoring
Initial Settings:
- IPAP: Start at 10-12 cmH₂O, titrate up to 15-20 cmH₂O as needed
- EPAP: 4-8 cmH₂O (offsets intrinsic PEEP, aids CO₂ clearance)
- FiO₂: Titrate to maintain target SpO₂
- Backup rate: 8-12 breaths/min
Critical Monitoring Points:
- Reassess within 1-2 hours maximum 2, 4
- Check arterial blood gases at 30-60 minutes 1
- Monitor for improvement in pH, PaCO₂, respiratory rate, and work of breathing
When BiPAP Fails - Intubation Criteria
Proceed immediately to intubation if 3, 5:
- No improvement or worsening within 1-2 hours
- Persistent respiratory acidosis (pH <7.35) despite NIV
- Hemodynamic instability or cardiogenic shock
- Inability to protect airway or clear secretions
- Patient intolerance despite adequate sedation
- PaO₂ <60 mmHg (8.0 kPa) or PaCO₂ >50 mmHg (6.65 kPa) with pH <7.35 despite maximal support 3
Important Caveats
BiPAP can worsen hemodynamics in PE patients 3. The positive intrathoracic pressure reduces venous return and can further compromise right ventricular function already stressed by the pulmonary embolism. Therefore:
- Monitor blood pressure closely - BiPAP may precipitate hypotension 3
- Avoid in patients with systolic BP <90 mmHg or signs of shock 3, 5
- Use cautiously with modest fluid challenge (≤500 mL) if central venous pressure is low 5
- Consider vasopressor support (norepinephrine) if hypotension develops 5
Alternative approaches for pure hypoxemic failure 6, 7, 6:
- High-flow nasal oxygen (HFNO) is preferred over BiPAP for de novo hypoxemic respiratory failure 6, 7, 6
- HFNO provides better tolerance, less hemodynamic compromise, and similar outcomes to NIV in hypoxemic failure 7, 6
- Consider HFNO at 40-60 L/min with FiO₂ 0.6-1.0 before escalating to BiPAP 7
The key distinction is that BiPAP is not the first-line choice for pure hypoxemic respiratory failure from PE - it is specifically indicated when there is concurrent hypercapnic respiratory failure with acidosis, typically in patients with underlying chronic respiratory disease 2, 3, 4.